Streetbeat News

Analyst Ratings

ESTC

In the last quarter, Elastic (NYSE:ESTC) received 8 bullish, 5 somewhat bullish, and 4 indifferent ratings from analysts. The company's average 12-month price target is $81.82, an increase of 6.61% from the previous average of $76.75.

Portfolio Pulse from Benzinga Insights

October 18, 2023 | 1:00 pm

MCD

McDonald's (NYSE:MCD) has seen a rise in short interest by 11.63% since its last report, with 6.95 million shares sold short, representing 0.96% of all regular shares available for trading. It would take traders 2.59 days on average to cover their short positions. The company's short interest as a percentage of float is less than its peer group average of 9.18%.

Portfolio Pulse from Benzinga Insights

October 18, 2023 | 1:00 pm

HWC

Raymond James analyst Michael Rose has maintained an Outperform rating on Hancock Whitney (NASDAQ:HWC) but lowered the price target from $46 to $45.

Portfolio Pulse from Benzinga Newsdesk

October 18, 2023 | 12:59 pm

SLB

Barclays analyst David Anderson maintains an Overweight rating on Schlumberger (NYSE:SLB) and raises the price target from $70 to $75.

Portfolio Pulse from Benzinga Newsdesk

October 18, 2023 | 12:53 pm

SBAC

Barclays analyst Brendan Lynch maintains an Overweight rating on SBA Comms (NASDAQ:SBAC) but has lowered the price target from $296 to $251.

Portfolio Pulse from Benzinga Newsdesk

October 18, 2023 | 12:52 pm

ORAN

Barclays analyst Maurice Patrick maintains an Overweight rating on Orange (NYSE:ORAN) but has lowered the price target from $13 to $12.5.

Portfolio Pulse from Benzinga Newsdesk

October 18, 2023 | 12:51 pm

MIDD

Barclays analyst Adam Seiden maintains an Overweight rating on Middleby (NASDAQ:MIDD) but lowers the price target from $177 to $160.

Portfolio Pulse from Benzinga Newsdesk

October 18, 2023 | 12:48 pm

MTZ

Barclays analyst Adam Seiden maintains an Overweight rating on MasTec (NYSE:MTZ) but lowers the price target from $120 to $106.

Portfolio Pulse from Benzinga Newsdesk

October 18, 2023 | 12:47 pm

LEGN

Barclays analyst Gena Wang maintains an Overweight rating on Legend Biotech (NASDAQ:LEGN) and raises the price target from $92 to $93.

Portfolio Pulse from Benzinga Newsdesk

October 18, 2023 | 12:46 pm

IBKR

Barclays analyst Benjamin Budish maintains an Overweight rating on Interactive Brokers Gr (NASDAQ:IBKR) and raises the price target from $110 to $112.

Portfolio Pulse from Benzinga Newsdesk

October 18, 2023 | 12:45 pm